Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07418450

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

Discrimination of N2a and N2b by EBUS-TBNA: is a Needle Change Necessary? - a Prospective Pilot Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEBUS-TBNADuring EBUS staging, the needle well be changed between all lymph node stations in a first round. The EBUS staging will be repeated without the change of the needle between the lymph node stations.

Timeline

Start date
2025-11-05
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2026-02-18
Last updated
2026-02-18

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT07418450. Inclusion in this directory is not an endorsement.